logo
  

AirMedia Announces Deal To Sell 75% Equity Interest Of AM Advertising

AirMedia Group Inc. (AMCN) announced that the company, AirMedia Technology (Beijing) Co., Ltd., which is a wholly owned subsidiary of the company in China, Beijing AirMedia Shengshi Advertising Co., Ltd., and Herman Guo have entered into a definitive equity interest transfer agreement with Beijing Longde Wenchuang Fund Management Co., Ltd. to sell 75% equity interest of AirMedia Group Co., Ltd., or AM Advertising, for a consideration of RMB 2.1 billion in cash.

Beijing AirMedia Shengshi Advertising Co., Ltd. is AirMedia's variable interest entity in China as well as the controlling shareholder of AM Advertising, and Herman Guo is deemed as actual controller of AM Advertising under PRC law.

AirMedia has agreed to restructure AM Advertising for the transaction. After the restructuring, AM Advertising is expected to own and operate all AirMedia's media business in airports and all the billboard and LED media outside of airports.

AirMedia Group said it may apply the consideration to dividend payments, and to support its fast growing new business of in-flight and on-train Wi-Fi services. AirMedia will hold an extraordinary general meeting to approve the transaction and the removal of the VIE structure of of AM Advertising.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT